Visceral leishmaniasis among liver transplant recipients: an overview.
Campos-Varela
Isabel
I
Liver Unit, Department of Internal Medicine, Hospital Universitari Vall Hebron, Barcelona, Spain.
Len
Oscar
O
Castells
Lluís
L
Tallada
Natalia
N
Ribera
Esteban
E
Dopazo
Cristina
C
Vargas
Víctor
V
Gavaldà
Joan
J
Charco
Ramón
R
D000666:Amphotericin B / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D008107:Liver Diseases / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
D000981:Antiprotozoal Agents; D000666:Amphotericin B